Navigation Links
Skin oil -- ozone interactions worsen air quality in airplanes
Date:9/5/2007

Airline passengers and crews who gripe about poor cabin air quality could have a new culprit to blame: the oils on their skin, hair and clothing. A study in the current issue of ACS Environmental Science & Technology suggests interactions between body oils and ozone found in airplane cabins could lead to the formation of chemical byproducts that might worsen nasal irritation, headaches, dry eyes and lips, and other common air traveler complaints.

In simulated flights lasting four hours, American and Danish researchers placed two groups of 16 volunteers in a mockup of an airline cabin and then exposed them to varying levels of ozone and air flow, including levels typically experienced in real flights. Consistently, ozone in the cabin increased production of identifiable chemical byproducts including nonanal and decanal, a pair of aldehyde compounds associated with headaches, nasal irritation and with other symptoms of sick building syndrome.

More than half of the byproducts were the result of reactions with skin, hair and clothing, according to Charles Weschler, Ph.D., the studys lead author, who is with University of Medicine and Dentistry of New Jersey. These oxidative byproducts are produced when ozone reacts with squalene, oleic acid and other compounds in natural skin oils, he said.

The role of these (by)products in the adverse health effects that have been associated with ozone is, at present, unknown, Weschler said. If these oxidation products are demonstrated to be harmful, simple steps can be taken to reduce their production in aircraft and buildings. For instance, installing ozone-destroying catalysts in airplane ventilation systems can help remove most of the ozone from incoming air, he noted.

In 2006, about 750 million people boarded commercial aircraft in the United States, according to the Federal Aviation Administration. At cruising altitude, the atmosphere outside of these aircraft contains very high ozone lev
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. NASAs AURA satellite peers into Earths ozone hole
2. Scientists find Antarctic ozone hole to recover later than expected
3. Atmospheric ozone recovering in mid-latitudes, report shows
4. UCI scientists find chlorine may contribute to ozone formation
5. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
6. Record ozone loss during 2006 over South Pole
7. In presence of fragrant cleaning products, air purifiers that emit ozone can dirty the air
8. Virus-host interactions at sea effect global photosynthesis
9. Computational verification of protein-protein interactions by orthologous co-expression
10. Complex gene interactions account for autism risk
11. A real time look at interactions between RNA and proteins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...burn Hills, MI-based Law Enforcement Intelligent D...ystem and patent-pending Biometric Access Control ... and Human Services, National Institutes of Health...ill support the NIH,s entire police force that is ...search agency. The project is expected to be comp...
(Date:11/5/2009)... a training grant in the amount of $2,756,719 by t...ve Graduation Education and Research Training (IGE...warded to Kent State. The grant, which is funded u... 2009, runs through 2014. , The grant funds an I...esource sensing (EARS). The purpose of the program...
(Date:11/4/2009)...hood obesity in the United States is reaching epid...ertising on daytime and prime time television devo...s about the role television plays in obesity, a st... of Nutrition Education and Behavior examines how...ge contributor to the problem. , Researchers at ...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Researchers Spot Genes Linked to Testicular Cancer 47451 1Researchers Spot Genes Linked to Testicular Cancer 47451 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 1FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 3FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 4FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 5FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 6
...ark December 13, 2007 The Juvenile Diabetes Rese...nder of type 1 diabetes research, awarded Professo...nhagens Department of Medical Biochemistry and Gen... cell regeneration and expansion during pregnancy ...or the treatment of type 1 diabetes. , The projec...
...University of Pennsylvania researchers have uncove... HSV-1, uses cooperating proteins found on its out...t them. Further, the studys authors say, they hav...se protein interactions using biomolecular complem...dings of the National Academy of Sciences, provide...
...ectly connect silicon circuits with brains are und...re nearing commercial application in many areas, a...ologist Theodore W. Berger of the University of So...ee which compiled the "International Assessment of...aces," published in October by the World Technolog...
Other Biology News:JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research 2Penn researchers shine the light of venus to learn how the herpes virus invades cells 2Brain-computer link systems on the brink of breakthrough, study finds 2
(Date:11/6/2009)... Nov. 6 Intarcia Therapeutics, Inc...0 (DUROS® continuous delivery of exenatide) p... Ninth Annual Diabetes Technology Meeting in San F.../cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Conti...650 Lowers Plasma Glucose, HbA1c and Reduces Weigh...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)...5 Imagenetix, Inc. (OTC ...m Spencer, President and CEO of Imagenetix, will b... LD MICRO Conference on Thursday, December 3rd, at..., About LD MICRO ,, LD MICRO is a by-invitat...ndervalued companies in the micro-cap space. Since...
(Date:11/5/2009).... 5 Transgenomic, Inc. (...l results for the quarter ended September 30, 2009... the tables that follow. ,, Third Quarter 2009...0 or $0.01 per share for the third quarter of 2009...r share for the third quarter of 2008. ,, Net ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
.... (Pink,Sheets: BMGP) has been rated Speculative B...esearch Analyst, Lisa Springer, CFA., The full re...., Anyone interested in receiving alerts regardin...members@beaconequity.com with "BMGP" in,the subje...magnetics Diagnostics Corp.,(BMGP) is a biotechnol...
...he nanoworld, researchers at the National Institut...rsity of Maryland-College Park have discovered tha...in bulk form behave as ductile as gold at the nano...re nanomachines. , NIST scientists Pradeep Namboo...ted* the latest incongruity between the macro and ...
...Nasdaq: DCGN ) today announced its consolidated f...cember 31, 2007. A conference call to discuss the,...bcast live tomorrow,Thursday, March 13, at 8:00am ...e year ended December 31, 2007 was $95.5 million,c...asic and diluted net,loss per share was $1.57 for ...
Other Biology Technology:BioMagnetics Diagnostics Corp. Rated 'Speculative Buy,' Target Price $1.42 by Beacon Equity Research 2Nanomaterials show unexpected strength under stress 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9
RNA oligos ready-to-use from Thermo Scientific
...m7G(5')ppp(5')G (Cap Analog) is used for the synth...ription reactions. Substitution of cap analog for ...ption reaction results in the incorporation of the...ripts. Capped mRNAs are generally translated more ...
iEMS Incubator/Shaker 2 module from Thermo Scientific
...Source: Pseudomonas atlantica Description: Beta-Ag...s from low-melting-temperature agarose. Beta-Agara...es. Tested User Friendly Properties: Heat Inactiva...mum pH: 6.5 Purity: Tested for contaminating endon...
Biology Products: